Ken Gatter

Medicine & Life Sciences

1. Neoadjuvant Therapy 100%
2. Esophageal Neoplasms 88%
3. Cytogenetics 71%
4. Esophagectomy 64%
5. Imatinib Mesylate 59%
6. Homologous Transplantation 58%
7. Chromosome Aberrations 58%
8. Mutation 58%
9. Acute Myeloid Leukemia 57%
10. Anaplastic small cell lymphoma 55%
11. Philadelphia Chromosome 44%
12. Pathologists 43%
13. Mesenchymal Chondrosarcoma 42%
14. Trisomy Chromosome 8 42%
15. Pure Red-Cell Aplasia 38%
16. Systemic Mastocytosis 38%
17. Erythema Infectiosum 37%
18. Biopsy 36%
19. Cytogenetic Analysis 36%
20. Mastocytosis 36%
21. Bone Marrow Failure Disorders 35%
22. Anaplastic Large-Cell Lymphoma 34%
23. Mycosis Fungoides 33%
24. Liposarcoma 33%
25. Neoplasms 33%
26. Chemoradiotherapy 32%
27. Burkitt Lymphoma 31%
28. B-Cell Chronic Lymphocytic Leukemia 31%
29. Medical Oncology 30%
30. Lymphoproliferative Disorders 30%
31. Survival 29%
32. Fluorescence In Situ Hybridization 28%
33. Skin 28%
34. B-Lymphocytes 28%
35. Allogeneic Cells 28%
36. Graft vs Host Disease 27%
37. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27%
38. Stem Cell Transplantation 27%
39. B-Cell Lymphoma 26%
40. Adenocarcinoma 26%
41. Bone Marrow Transplantation 26%
42. Leukemia 26%
43. Fine Needle Biopsy 26%
44. Bone Marrow 23%
45. Drug Resistance 23%
46. Liver Transplantation 23%
47. Lymph Node Ratio 22%
48. Cell Biology 22%
49. Karyotyping 22%
50. Chromosomes, Human, Pair 7 22%